Brain-Derived Neurotrophic Factor-TrkB Pathway on Synaptic Plasticity in Ischemic Stroke Rats

Area of Science:

• Neuroscience
• Biomedical Research
• Stroke Pathophysiology

Background:

• Stroke is a significant and increasing global health concern.
• Understanding molecular mechanisms post-stroke is crucial for developing effective treatments.
• The BDNF-TrkB pathway plays a role in neuronal survival and plasticity.

Purpose of the Study:

• To investigate the role of the BDNF-TrkB signaling pathway in a rat model of cerebral ischemia-reperfusion.
• To examine the expression of synaptic plasticity markers following stroke.
• To determine the impact of blocking the BDNF-TrkB pathway on stroke-induced changes.

Main Methods:

• Establishment and validation of a rat middle cerebral artery occlusion (MCAO) model for cerebral ischemia-reperfusion.
• Quantification of key protein expression in the BDNF-TrkB pathway at various time points post-stroke.
• Assessment of synaptic plasticity markers, including SYP, PSD-95, and MAP-2.
• Pharmacological blockade of the BDNF-TrkB pathway using K252a.

Main Results:

• BDNF (Brain-Derived Neurotrophic Factor) expression significantly increased during the acute phase after MCAO.
• Expression levels of synaptic plasticity markers (SYP, PSD-95, MAP-2) decreased post-stroke.
• Inhibition of the BDNF-TrkB pathway with K252a demonstrated a significant effect on these changes.

Conclusions:

• The BDNF-TrkB signaling pathway is dynamically altered following cerebral ischemia-reperfusion.
• Changes in the BDNF-TrkB pathway are associated with compromised synaptic plasticity in stroke.
• Targeting the BDNF-TrkB pathway may represent a therapeutic strategy for stroke recovery.